Abcellera Biologics Inc ABCL

$11.62 -0.33 (-2.76%)

Valuation

Market cap
3,903,085,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
3,154,900
Avg volume
4,311,480
Day's range
$11.24 – $12.01
Shares out
326,618,000
Stochastic %K
39%
Beta
1.59
Analysts
Strong Buy
Price target
$17.92

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

flymetothemoon2 Nov 13, 3:51 PM
$ABCL
0 replies
Rastafari Nov 13, 3:30 PM
$ABCL enjoy the weekend folks. Tough week, but lots of positive news to absorb! Share price will reflect reality soon!
1 replies
erpy Nov 13, 3:27 PM
$ABCL Erpy done adding for today. Time to let the sun shine !!
0 replies
flymetothemoon2 Nov 13, 3:26 PM
$ABCL ❤️ ABcellera 🔥 🔥!!!
1 replies
erpy Nov 13, 3:22 PM
$ABCL Lets go dont be skeered. Jmho
1 replies
Buying_Low_Selling_High Nov 13, 3:22 PM
$ABCL Couldn't resist. Bought more.
1 replies
Ckkung71 Nov 13, 3:14 PM
$ABCL Can someone update all price target right now please 🙏
1 replies
erpy Nov 13, 3:12 PM
$ABCL Big money loading and retail shaking in their boots. Thats how the market works now with all the algos. The CEO tries to show retail the light. I can only say pay attention. I do. .. Learn to buy fear!!
0 replies